An Open Label Extension Study of the Efficacy of MORAb-003
NCT01018563
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
3
Enrollment
INDUSTRY
Sponsor class
Stopped
Study was terminated by sponsor due to futile results in NCT00849667 study.
Conditions
Epithelial Ovarian Cancer
Interventions
DRUG:
MORAb-003
Sponsor
Morphotek